Amgen, a leading biotechnology company, has recently announced the appointment of Naveen Gullapalli as the Managing Director of its India operations. This move highlights the company’s commitment to driving technology and innovation from its Hyderabad site. Gullapalli, who brings extensive expertise in global operations across pharmaceuticals, finance, and technology, will oversee the Amgen India Technology and Innovation hub.
Prior to joining Amgen, Gullapalli played a crucial role in establishing and expanding Novartis’ Global Centre in Hyderabad and five other global centres. He has been instrumental in driving innovation and strategic growth for the company. In his new role, Gullapalli will be responsible for driving the success of Amgen’s new site in Hyderabad, which was announced in August 2024.
According to Som Chattopadhyay, National Executive for India at Amgen, the company’s India operations are crucial in achieving its global vision of unlocking the convergence of biotech and tech to accelerate innovation and meet the needs of an aging population. He believes that Gullapalli’s wealth of experience and strategic leadership will be instrumental in achieving this goal.
Amgen’s Hyderabad facility, which will span six floors of the RMZ Spire Tower 110, is a key part of the company’s global strategy to drive digital transformation and innovation. The centre will focus on scaling advanced technologies and enhancing capabilities in AI, data science, and life sciences to streamline operations and support the company’s mission of serving more patients globally.
Hyderabad was chosen as the location for this facility due to its strong talent pool in medicine, life sciences, data sciences, and AI. With nearly 27,000 employees, Amgen has a global presence in approximately 100 countries and regions, including India. With over 40 years of experience in the industry, the company continues to advance a broad pipeline of treatments for various diseases and conditions.
In conclusion, Amgen’s appointment of Naveen Gullapalli as the Managing Director of its India operations is a testament to the company’s commitment to driving technology and innovation in the biotech industry. With Gullapalli’s leadership and expertise, Amgen is well-positioned to achieve its global vision and serve more patients globally.
